✦ LIBER ✦

RANDOMISED PHASE III TRIAL OF THE MULTIKINASE INHIBITOR SORAFENIB (BAY 43-9006) IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)

✍ Scribed by Escudier, B.; Szczylik, C.; Eisen, T.; Oudard, S.; Stadler, W.M.; Schwartz, B.; Shan, M.; Bukowski, R.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

794 ORAL Randomized Phase III trial of t

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

795 ORAL Phase II trial of sorafenib (BA

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 273 KB

7141 POSTER Phase II Trial of the Oral M

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

883 POSTER Phase I trial of sorafenib (B

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

7105 Phase II trial of the oral multikin

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

7130 Efficacy and safety of sorafenib in

✍ Bukowski, R.; Eisen, T.E.; Stadler, W.S.; Szczylik, C.S.; Oudard, O.S.; Siebels, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB